These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32972348)

  • 1. Advances in Synthesis, Derivatization and Bioactivity of Isatin: A Review.
    Chauhan G; Pathak DP; Ali F; Bhutani R; Kapoor G; Khasimbi S
    Curr Org Synth; 2021; 18(1):37-74. PubMed ID: 32972348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro Evaluation of Isatin Derivatives as Potent Anti-Breast Cancer Agents against MCF-7, MDA MB 231, MDA-MB 435 and MDA-MB 468 Breast Cancers Cell Lines: A Review.
    Chauhan G; Pathak DP; Ali F; Dubey P; Khasimbi S
    Anticancer Agents Med Chem; 2022; 22(10):1883-1896. PubMed ID: 34477529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advancement of Synthesis of Isatins as a Versatile Pharmacophore: A review.
    Kumar G; Singh NP; Kumar K
    Drug Res (Stuttg); 2021 Mar; 71(3):115-121. PubMed ID: 33296925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Outcomes of Isatin and Its Derivatives against Multiple Diseases: Recent Developments in Drug Discovery.
    Cheke RS; Patil VM; Firke SD; Ambhore JP; Ansari IA; Patel HM; Shinde SD; Pasupuleti VR; Hassan MI; Adnan M; Kadri A; Snoussi M
    Pharmaceuticals (Basel); 2022 Feb; 15(3):. PubMed ID: 35337070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isatin Hybrids and Their Pharmacological Investigations.
    Varpe BD; Kulkarni AA; Jadhav SB; Mali AS; Jadhav SY
    Mini Rev Med Chem; 2021; 21(10):1182-1225. PubMed ID: 33302835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis biological evaluation and molecular docking of isatin hybrids as anti-cancer and anti-microbial agents.
    Altamimi M; Syed SA; Tuzun B; Alhazani MR; Alnemer O; Bari A
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2288548. PubMed ID: 38073431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and pharmacological characterization of isatin and its derivatives: from structure to activity.
    Pakravan P; Kashanian S; Khodaei MM; Harding FJ
    Pharmacol Rep; 2013; 65(2):313-35. PubMed ID: 23744416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isatin dimers and their biological activities.
    Zhang YZ; Du HZ; Liu HL; He QS; Xu Z
    Arch Pharm (Weinheim); 2020 Mar; 353(3):e1900299. PubMed ID: 31985855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic and anticancer activities of isatin and its derivatives: a comprehensive review from 2000-2008.
    Vine KL; Matesic L; Locke JM; Ranson M; Skropeta D
    Anticancer Agents Med Chem; 2009 May; 9(4):397-414. PubMed ID: 19442041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isatin: A Scaffold with Immense Biodiversity.
    Nath P; Mukherjee A; Mukherjee S; Banerjee S; Das S; Banerjee S
    Mini Rev Med Chem; 2021; 21(9):1096-1112. PubMed ID: 33238872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
    Yang M; Liu H; Zhang Y; Wang X; Xu Z
    Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Recent Perspective on Discovery and Development of Diverse Therapeutic Agents Inspired from Isatin Alkaloids.
    Rane RA; Karunanidhi S; Jain K; Shaikh M; Hampannavar G; Karpoormath R
    Curr Top Med Chem; 2016; 16(11):1262-89. PubMed ID: 26369813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Journey and Recent Advances in the Synthesis of Coumarin Derivatives.
    Sinha S; Singh K; Ved A; Hasan SM; Mujeeb S
    Mini Rev Med Chem; 2022; 22(9):1314-1330. PubMed ID: 34784861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in 1,2,3- and 1,2,4-triazole hybrids as antimicrobials and their SAR: A critical review.
    Tian G; Song Q; Liu Z; Guo J; Cao S; Long S
    Eur J Med Chem; 2023 Nov; 259():115603. PubMed ID: 37478558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, Characterization, and Antibacterial Activity of New Isatin Derivatives.
    Nain S; Mathur G; Anthwal T; Sharma S; Paliwal S
    Pharm Chem J; 2023; 57(2):196-203. PubMed ID: 37313436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoroquinolone-isatin hybrids and their biological activities.
    Xu Z; Zhao SJ; Lv ZS; Gao F; Wang Y; Zhang F; Bai L; Deng JL
    Eur J Med Chem; 2019 Jan; 162():396-406. PubMed ID: 30453247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and anti-inflammatory activity evaluation of novel triazolyl-isatin hybrids.
    Sharma PK; Balwani S; Mathur D; Malhotra S; Singh BK; Prasad AK; Len C; Van der Eycken EV; Ghosh B; Richards NG; Parmar VS
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1520-6. PubMed ID: 27146339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indole/isatin-containing hybrids as potential antibacterial agents.
    Song F; Li Z; Bian Y; Huo X; Fang J; Shao L; Zhou M
    Arch Pharm (Weinheim); 2020 Oct; 353(10):e2000143. PubMed ID: 32667714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in isatin hybrids as potential anticancer agents.
    Ding Z; Zhou M; Zeng C
    Arch Pharm (Weinheim); 2020 Mar; 353(3):e1900367. PubMed ID: 31960987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of Novel Class of N-Alkyl-isatin-3-iminobenzoic Acid Derivatives and Their Biological Activity in Zebrafish Embryos and Human Cancer Cell Lines.
    Farooq M; Al Marhoon ZM; Taha NA; Baabbad AA; Al-Wadaan MA; El-Faham A
    Biol Pharm Bull; 2018 Mar; 41(3):350-359. PubMed ID: 29249771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.